Table 4.
Laboratory and clinical data of the patients with and without POF.
| Laboratory data | ||||
| Hemoglobin, /L | 142.07 ± 27.54 | 137.86 ± 26.18 | 156.8026.57 | 0.001 |
| Platelet count, ×109/L | 199.61 ± 61.49 | 202.98 ± 57.85 | 187.80 ± 72.68 | 0.234 |
| Serum glucose, mmol/L | 8.90 ± 4.15 | 7.80 ± 2.79 | 12.76 ± 5.65 | <0.001 |
| Aspartate aminotransferase, U/L | 96.52 ± 144.83 | 101.46 ± 157.22 | 79.23 ± 88.80 | 0.461 |
| Albumin, g/L | 36.43 ± 5.57 | 37.53 ± 4.95 | 32.56 ± 5.95 | <0.001 |
| Serum calcium, mmol/L | 2.04 ± 0.29 | 2.13 ± 0.21 | 1.71 ± 0.31 | <0.001 |
| Platelet distribution width, % | 15.48 ± 2.46 | 14.88 ± 2.24 | 17.60 ± 1.96 | <0.001 |
| Severity scores | ||||
| ∗Ranson score | 3.68 ± 1.86 | 3.37 ± 1.87 | 4.77 ± 1.41 | <0.001 |
| ∗SIRS score | 2.30 ± 1.02 | 2.13 ± 1.01 | 2.90 ± 0.84 | <0.001 |
| Outcomes | ||||
| PNec | 46 (34.1%) | 21 (20.0%) | 25 (83.3%) | <0.001 |
| In-hospital mortality | 11 (8.1%) | 0 (0.0%) | 11 (36.7%) | <0.001 |
POF: persistent organ failure; PNec: pancreatic necrosis. ∗Ranson scoring system: (1) age > 55 years; (2) serum glucose > 11.1 mmol/L; (3) aspartate aminotransferase > 250 U/L; (4) lactate dehydrogenase > 350 U/L; (5) white blood count > 16 × 109/L; (6) hematocrit decrease > 10%; (7) serum urea increase > 1 mmol/L; (8) PaO2 < 60 mmHg; (9) serum calcium < 2 mmol/L; (10) base deficiency > 4 mmol/L; and (11) fluid loss > 6 L. Each event represents one point. ∗SIRS scoring system: (1) heart rate > 90 bpm; (2) temperature > 38°C or <36°C; (3) white blood count > 12 × 109/L or < 4 × 109/L; (4) breath rate > 20 bpm; and (5) PCO2 < 32.33 mmHg. Each event represents one point.